Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1 12Phase 1/2 7Phase 3 2Phase NA 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Tumor-Agnostic 2Gastrointestinal 2Head & Neck 1CNS 1Breast 1

Conditions

Neoplasms 1Glioma 1

Interventions

Magnetic Resonance Spectroscopy 52Radiosurgery 38Radiotherapy 24Blood Specimen Collection 21Magnetic Resonance Imaging 17Bevacizumab 16Temozolomide 13Radiation 12Proton Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Mental Status and Dementia Tests 9Carboplatin 9Surgical Procedures, Operative 8Exercise 8Dexmedetomidine 8Vincristine 7Surveys and Questionnaires 7Spinal Puncture 7Etoposide 7Drug Therapy 7Biopsy 7Saline Solution 6Diffusion Tensor Imaging 6Dexamethasone 6Cyclophosphamide 6Therapeutics 5Standard of Care 5Restraint, Physical 5Propofol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Erlotinib Hydrochloride × CNS × Clear all
NCT02239952 2020-10-08

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Amsterdam UMC, location VUmc

Phase NA Unknown
15 enrolled
CNS

Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡